Apexigen Financial Statements From 2010 to 2024
| APGNWDelisted Stock | USD 0.02 0.0001 0.66% |
Check Apexigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apexigen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Apexigen financial statements analysis is a perfect complement when working with Apexigen Valuation or Volatility modules.
Apexigen |
Apexigen Company Cash Per Share Analysis
Apexigen's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Apexigen Cash Per Share | 0.69 X |
Most of Apexigen's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apexigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Apexigen has a Cash Per Share of 0.69 times. This is 84.14% lower than that of the Biotechnology sector and 84.06% lower than that of the Health Care industry. The cash per share for all United States stocks is 86.23% higher than that of the company.
Apexigen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apexigen's current stock value. Our valuation model uses many indicators to compare Apexigen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apexigen competition to find correlations between indicators driving Apexigen's intrinsic value. More Info.Apexigen is rated fifth in number of shares shorted category among its peers. It is rated third in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Apexigen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Apexigen Financial Statements
Apexigen investors use historical fundamental indicators, such as Apexigen's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apexigen. Please read more on our technical analysis and fundamental analysis pages.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. The company was founded in 2010 and is based in San Carlos, California. Apexigen Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |